These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38124235)

  • 1. Protocol for a national audit of the watch-and-wait approach in patients with rectal cancer in Aotearoa New Zealand: The ACCORD study.
    STRATA Collaborative
    Colorectal Dis; 2024 Feb; 26(2):371-379. PubMed ID: 38124235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study.
    Fernandez LM; São Julião GP; Figueiredo NL; Beets GL; van der Valk MJM; Bahadoer RR; Hilling DE; Meershoek-Klein Kranenbarg E; Roodvoets AGH; Renehan AG; van de Velde CJH; Habr-Gama A; Perez RO;
    Lancet Oncol; 2021 Jan; 22(1):43-50. PubMed ID: 33316218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol.
    Vatandoust S; Wattchow D; Sposato L; Michael MZ; Leung J; Gormly K; Chen G; Symonds EL; Tie J; Papanicolas LE; Woods S; Gebski V; Mead K; Kuruni A; Karapetis CS
    BMC Cancer; 2022 Mar; 22(1):222. PubMed ID: 35232427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 6. Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait".
    Lai CL; Lai MJ; Wu CC; Jao SW; Hsiao CW
    Int J Colorectal Dis; 2016 Feb; 31(2):413-9. PubMed ID: 26607907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
    Dossa F; Chesney TR; Acuna SA; Baxter NN
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy.
    Crean R; Glyn T; McCombie A; Frizelle F
    ANZ J Surg; 2024 Jun; 94(6):1151-1160. PubMed ID: 38486505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
    Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
    [No Abstract]   [Full Text] [Related]  

  • 13. Total neoadjuvant therapy followed by a watch-and-wait strategy for patients with rectal cancer (TOWARd): protocol for single-arm phase II/III confirmatory trial (JCOG2010).
    Hashimoto T; Tsukamoto S; Murofushi K; Ito Y; Hirano H; Tsukada Y; Sasaki K; Mizusawa J; Fukuda H; Takashima A; Kanemitsu Y
    BJS Open; 2023 Nov; 7(6):. PubMed ID: 37931233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particular aspects of treating rectal cancer: The watch and wait approach.
    Draghici DA; Stoian AR; Porojan VA; David OI; Bedereag Ş; Ciuhu AN; Haidar A; Creţoiu D; Condrat CE; Grigorean VT
    J Cancer Res Ther; 2023; 19(2):461-469. PubMed ID: 37006080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?
    Kaul S; Rao C; Mane R; Tan KL; Khan AHA; Hussain MS; Shafi MA; Buettner F; Banerjee S; Boulton R; Bhargava A; Huang J; Hanson M; Raouf S; Ball S; Rajendran N
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e25-e34. PubMed ID: 34454807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of a watch-and-wait approach in patients with a complete clinical response to chemoradiotherapy for rectal cancer.
    Cooper EA; Hodder RJ; Finlayson A; Filgate R; Coveney A; Balasuriya HD; Warner MW
    ANZ J Surg; 2022 Nov; 92(11):2956-2960. PubMed ID: 35855528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management.
    Weiser MR; Chou JF; Kim JK; Widmar M; Wei IH; Pappou EP; Smith JJ; Nash GM; Paty PB; Cercek A; Saltz LB; Romesser PB; Crane CH; Garcia-Aguilar J; Schrag D; Gönen M
    JAMA Netw Open; 2022 Sep; 5(9):e2233859. PubMed ID: 36173634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy.
    Wang QX; Zhang R; Xiao WW; Zhang S; Wei MB; Li YH; Chang H; Xie WH; Li LR; Ding PR; Chen G; Zeng ZF; Wang WH; Wan XB; Gao YH
    Radiat Oncol; 2021 Jan; 16(1):16. PubMed ID: 33468176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes.
    Neşşar G; Demirbağ AE; Mısırlıoğlu HC; Sezer S
    Turk J Gastroenterol; 2019 Nov; 30(11):951-956. PubMed ID: 31767549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
    Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.